Angioscopic evaluation of stabilizing effects of an antilipemic agent, bezafibrate, on coronary plaques in patients with coronary artery disease: A multicenter prospective study

Japanese Heart Journal

Volumn 43, Issue 4, 2002, Pages 319-331

  Ohsawa, Hidefumi ^a   Uchida, Yasumi ^a   Fujimori, Yoshiharu ^b   Hirose, Junichi ^c   Noike, Hirofumi ^a   Tokuhiro, Keiichi ^a   Kawamura, Kohei ^a   Kanai, Masahito ^a   Sakuragawa, Hiroshi ^a   Hitsumoto, Takashi ^a   Aoyagi, Kaneyuki ^a   Sakurai, Takeshi ^a   Sato, Shin ^a   Yoshinaga, Kunio ^a   Kaku, Michihisa ^a   Ozegawa, Masaaki ^b   Morio, Hiroshi ^b   Yamada, Katsumi ^b   Terasawa, Kimiko ^b   Uchida, Yuuko ^b   Ohshima, Tomomitsu ^c   more..

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NARITA RED CROSS HOSPITAL   (Japan)

^c Funabashi Futawa Hospital   (Japan)

Author keywords

Angioscopy; Bezafibrate; Coronary plaque; Plaque stabilization

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BEZAFIBRATE; CALCIUM ANTAGONIST; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LONG ACTING DRUG; NITRATE; POTASSIUM CHANNEL STIMULATING AGENT; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ANGIOSCOPE; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; DIET THERAPY; DRUG EFFICACY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LONG TERM CARE; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME; ANGIOSCOPY; BLOOD; CORONARY ARTERY DISEASE; MIDDLE AGED; MULTICENTER STUDY;

ANGIOSCOPY; ANTILIPEMIC AGENTS; BEZAFIBRATE; CHOLESTEROL; CHOLESTEROL, HDL; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 19044367729     PISSN: 00214868     EISSN: 1348673X     Source Type: Journal    
DOI: 10.1536/jhj.43.319     Document Type: Article

References (15)

1. Waters D, Higgins L, Gladstone P, et al. Effect of lovastatin upon the evolution of coronary atherosclerosis as assessed by serial quantitative coronary arteriography. J Am Coll Cardiol l993; 21: 1312-8.
2. The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
3. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New Engl J Med 1995; 333: 1301-7.
4. Jakema JW, Bruschke AVG, van Boven AJ, et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. Circulation 1995; 91: 2528-40.
5. Ericsson CG, Hamsten A, Nilsson J, et al. Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet 1996; 347: 849-53.
6. Ericsson CG, Nilsson J, Grip L, et al. Effects of bezafibrate treatment over five years on coronary plaques causing 20% to 50% diameter narrowings (The Bezafibrate Atherosclerosis Intervention Trial). Am J Cardiol 1997; 80: 1125-9.
7. Ericsson CG. Results of the bezafibrate coronary atherosclerosis trial (BECAIT) and an update on trials now in progress. Eur Heart J 1998; 19: H37-41.
8. Yutani C, Hao H. Histopathological study of acute myocardial infarction and pathoetiology of coronary thrombosis: A comparative study in four districts in Japan. Jpn Circ J 1987; 51: 352.
9. Hao H, Yutani C. Histopathological aspects of coronary thrombosis and its progression. In Japanese Journal of Clinical Medicine 1994; 52: 121-7.
10. Uchida Y, Nakamura F, Tomaru T, et al. Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina. Am Heart J 1995; 130: 204-11.
11. MAAS investigators. Effect of simvastatin on coronary atheroma: the Multicentere Anti-Atheroma Study (MAAS). Lancet 1994; 344: 633-8.
12. Uchida Y, Kanai M, Uchida H, et al. Angioscopic classification of coronary plaques and its pathological correlations. Coronary 1999; 16: 302-13.
13. Uchida Y, Takeuchi K, Kanai M, et al. Glistening yellow plaque, a vulnerable plaque, and its pathological correlations. Circulation 1999; 100 (Suppl 1): 514.
14. Uchida Y. Angioscopic detection of vulnerable plaques and prediction of acute coronary syndromes. In: Fuster V, editor. The Vulnerable Atherosclerotic Plaque. New York: Futura 1999: 111-29.
15. Sherman CT, Litback F, Grundfest W. Coronary angioscopy in patients with unstable angina pectoris. New Engl J Med l986; 315: 913-9.